Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023
SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
20,300€
Echtzeit-Aktienkurs Myriad Genetics Inc.
Bid:
Ask:
Nachrichten zur Myriad Genetics Inc. Aktie
United States Women Health Laboratory Testing Markets Report 2022-2030 Featuring Ascension, EKF, Gateway Genomics, Laboratory Corp of America, Myriad Genetics, Natera, Ovia Health, Roche, & Yourgene
DUBLIN, Feb. 20, 2023 /PRNewswire/ -- The "U.S. Women Health Laboratory Testing Market - A Region-Wise Analysis: Focus on U.S.…
Myriad Genetics to Participate in Upcoming Healthcare Conferences
SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Myriad Genetics Highlights 2022 Research Findings that Help Advance More Accessible and Equitable Genetic Testing
SALT LAKE CITY, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Insiderhandel: Chief Financial Officer verkauft Aktien von Myriad Genetics im Wert von 188.386$
Riggsbee, Richard Bryan - Vorstand - Tag der Transaktion: 2023-01-20...…
Insiderhandel: Chief Financial Officer verkauft Aktien von Myriad Genetics im Wert von 12.006$
Riggsbee, Richard Bryan - Vorstand - Tag der Transaktion: 2023-01-18...…
Myriad Genetics upgraded to outperform from market perform at Raymond James
Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics (MYGN) Ailed by Mounting Costs, FX Headwind
Myriad Genetics (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning....…
Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities
SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Insiderhandel: Chief Financial Officer verkauft Aktien von Myriad Genetics im Wert von 302.992$
Riggsbee, Richard Bryan - Vorstand - Tag der Transaktion: 2022-12-27...…
Myriad Genetics names new marketing chief, and makes other key appointments
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics Hires Five Senior Leaders to Advance Commercial Growth Plans
SALT LAKE CITY, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model
Myriads MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries Myriads…
Immunovia strengthens US organization to continue commercialization of its novel IMMray™ PanCan-d test
LUND (SWEDEN) – Immunovia (Nasdaq Stockholm: IMMNOV), the diagnostics company that has launched the worlds first blood test dedicated to…
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Why Shares of Myriad Genetics Dropped 24% This Week
The genetic-testing company announced an acquisition and lowered its guidance....…
Myriad Genetics Q3 Earnings Fall Short Of Expectations, Lowers Annual Outlook
read more...…
Myriad Genetics Shares Drop 18% on Lower 2022 Guidance
Myriad Genetics Shares Drop 18% on Lower 2022 Guidance...…
Myriad Genetics (MYGN) Reports Q3 Loss, Lags Revenue Estimates
Myriad (MYGN) delivered earnings and revenue surprises of -375% and 9.13%, respectively, for the quarter ended September 2022. Do the…
Myriad Genetics falls 19% after lowering full-year guidance, Q3 misses
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics Slashes FY22 Outlook As Q3 Results Miss Estimates; Stock Down 8%
WASHINGTON (dpa-AFX) - While reporting financial results for the third quarter on Tuesday, genetic testing firm Myriad Genetics, Inc. (MYGN)…
Myriad Genetics Non-GAAP EPS of -$0.19 misses by $0.11, revenue of $156.4M misses by $13.97M, updates FY guidance
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics Reports Third Quarter Financial Results
Highlights:...…
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
SALT LAKE CITY, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Form 8-K MYRIAD GENETICS INC For: Nov 01
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics Expands Board of Directors with Election of Paul M. Bisaro as New Board Member
SALT LAKE CITY, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Myriad Genetics Q3 2022 Earnings Preview
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022
SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign
TUCSON, Ariz., Oct. 13, 2022 /PRNewswire/ -- Learn Look Locate (LLL) announced a partnership with Myriad Genetics, a leader in…